Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis.
Gerard T GiblinSarah A M CuddyEsther González-LópezAlanna SewellAmanda MurphySharmila DorbalaRodney H FalkPublished in: European heart journal. Cardiovascular Imaging (2022)
In ATTR-CM, tafamidis resulted in a lesser deterioration in GLS, myocardial work index, and efficiency over a 12-month period compared with a cohort not treated with tafamidis.